CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Nurix Says First Patient Enrolled in Phase 1b/2 Lymphocytic Leukemia Combination Study

Phase 1Neutral
AI Analysis

Summary

Nurix announced that the first patient has been enrolled in a Phase 1b/2 combination study for lymphocytic leukemia treatment.

Clinical Trial Data

Phase

1b/2

Importance:3/10
Sentiment:
0.00
clinical_triallymphocytic_leukemiaphase_1b_2patient_enrollment
Related Companies

Read the original article

Published by yahoo_finance on October 7, 2026 8:17 AM

Read Original